WORKSHOP 3: Health Data as an Asset: Tools to Manage Provenance, Appropriability, Governance, & Monetization
WORKSHOP 4: Think Globally, Act Globally: Cross Border Considerations in Global Strategic Partnerships, M&A, and Risk Management
WORKSHOP 5: Maximizing the Value of Corporate IP Assets: Strategies for an Ever-Evolving Global Landscape
PLENARY PANEL: Creating Value: Licensing and Partnering Strategies in Leading Innovation-Based Companies
WORKSHOP 9: The VentureWell ‘FLIPspace’ Program: A Model for Technology Commercialization Education, Partnerships & Impact
WORKSHOP 13: How to Streamline Access to Patient Materials and Data Across Entities to Accelerate Strategic Partnerships and Development of New Medicines
WORKSHOP 14: Artificial Intelligence (AI) Applications and Implications: Recent Developments, Opportunities and Mitigating Risks
ROUNDTABLE 3: Enforcing Your IP Worldwide: Effective Use of the New European Patent System as Part of your Global Patent Strategy
